The 1 analysts offering 12-month price forecasts for Kintara Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +1,071.87% increase from the last price of 0.26.
The current consensus among 1 polled investment analysts is to Hold stock in Kintara Therapeutics Inc. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.02
Reporting Date Sep 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.